Format

Send to

Choose Destination
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jun;19(6):881-3. doi: 10.1007/s00192-007-0553-z.

1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence.

Author information

1
Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.

Abstract

We hereby report a 1-year follow-up on eight women in the first North America trial in which stress urinary incontinence (SUI) was treated with muscle-derived stem cell injections. Mean and median follow-up in this group was 16.5 and 17 months (range 3-24 months). Improvement in SUI was seen in five of eight women, with one achieving total continence. Onset of improvement was between 3 and 8 months after injection. Cure or improvement continued at a median of 10 months. No serious adverse events were reported.

PMID:
18204978
DOI:
10.1007/s00192-007-0553-z
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center